Drug-delivery Systems of Phytochemicals as Therapeutic Strategies in Cancer Therapy elucidates the importance of various phytochemicals in cancer therapy and explains various routes/methods to deliver phytochemicals for overcoming the problems associated with delivery systems in cancer treatment. Several nanotechnological methods are presented to enhance drug solubility, sustainability, bioavailability, and gastrointestinal permeability of these phytochemicals. Current understanding of the relevant information presented on therapeutic strategies in cancer therapy fulfils the requirements of oncologists, molecular biologists, pharmacologist and related researchers who want to work in the areas of drug development targeting phytochemicals for cancer therapy.
- Explains the significance of phytochemicals in cancer therapy, along with their pharmacologic action
- Elucidates the importance of various phytochemicals in cancer therapy
- Explains the emerging need of drug-delivery system for plant metabolites
- Deciphers the various drug-delivery systems for phytomedicines involved in cancer treatments
- Describes the crucial role of nanotechnology in the development of drug-delivery systems for anticancer phytochemicals
- Explores the challenges associated with developing drug-delivery systems for phytochemicals to cure cancer
Dr. Mamta Bisht is presently working as an Assistant Professor in Department of Chemistry, School of Applied and Life Sciences, Uttaranchal University (NAAC A+), Dehradun, Uttarakhand India. She is actively involved in the extraction, isolation, characterization of “Natural Products” obtained from the medicinal and aromatic plants with bioactivity since last 8 years. Besides this her analytical skill is in GC, GC-MS, HPLC, Prep- HPLC and HPTLC. Further, she is equally involved in the promotion of endangered and economically important species from the Youngest Himalayan region. She has been published more than fifteen papers in peer-reviewed international journal and seven book chapter. Further, she has been participated more than ten conferences including national and international. She is life time member of Indian Science Congress Association. Under her guidance many P.G. and U.G. student successfully completed her Project Thesis and some students are working with her. She is also guided the Ph. D students in the University.
Divya Singh is presently working as Scientist-B in Department of Mulberry Physiology, CSRTI, Mysore, India. Her research specialization is primarily in genetics, proteomics, metabolomics, toxicology, bioinformatics and molecular biological evaluation in various in vivo and in vitro plant models to elucidate the physiological changes and evaluate the DNA damage potency. In her 11 years of research experiences, she has published 8-peer reviewed publications, two books (1 edited and 1 authored) including 6 book chapters and several meeting presentations at local and international scientific meetings.
Dr. Rajesh Kumar Singh is currently working as a Research Associate in Banaras Hindu University. His research focus is pharmacognosy, reverse pharmacology, drug design and discovery, extraction & isolation of natural products, cell culture, and handling of different rodents. He has published several research articles in reputable journals over the course of his career. At present, he is involved in developing an Indian origin cell line and screening drugs of natural origin for the treatment of gallbladder cancer.
